peptide-1

By Targets:	Amyloid-β (15) CGRP Receptor (2) Formyl Peptide Receptor (FPR) (2) ADC Linker (1) Amino Acid Derivatives (2) Angiotensin Receptor (6) Angiotensin-converting Enzyme (ACE) (3) Antibiotic (1) Apoptosis (1) Bacterial (4) Bcl-2 Family (1) Biochemical Assay Reagents (5) Calmodulin (1) Cholinesterase (ChE) (1) Dipeptidyl Peptidase (7) Endogenous Metabolite (4) FAAH (1) Fluorescent Dye (5) Fungal (1) Gap Junction Protein (2) GCGR (54) GLP Receptor (23) GnRH Receptor (3) GPR119 (2) GPR35 (1) GSK-3 (3) HCV (2) HCV Protease (2) Histamine Receptor (1) IFNAR (1) Integrin (2) Interleukin Related (1) Isotope-Labeled Compounds (3) NOD-like Receptor (NLR) (2) Opioid Receptor (1) Protease Activated Receptor (PAR) (5) Proteasome (1) SARS-CoV (2) Src (1) Tau Protein (1) TRP Channel (1) Vasopressin Receptor (1)
By Research Areas:	Cancer (18) Cardiovascular Disease (17) Endocrinology (6) Infection (8) Inflammation/Immunology (11) Metabolic Disease (85) Neurological Disease (40)
Click Chemistry:	TCO (1)

Targets Recommended: Formyl Peptide Receptor (FPR) CGRP Receptor Amyloid-β

Cat. No.	Product Name	Target	Research Areas	Chemical Structure

HY-P3414A

*Proteasome-activating peptide 1* TFA** 1 Publications Verification	Proteasome	Neurological Disease
Proteasome-activating peptide 1 TFA is a peptide and a potent proteasome activator. Proteasome-activating peptide 1 TFA increases the chymotrypsin-like proteasomal catalytic activity and, consequently, proteolytic rates both in vitro and in culture. Proteasome-activating peptide 1 TFA prevents protein aggregation in a cellular model of amyotrophic lateral sclerosis ^[1].

HY-P2547

Tyrosine Kinase Peptide 1

Src Others

Tyrosine Kinase Peptide 1 is a control substrate peptide for c-Src assay ^[1].

Tyrosine Kinase Peptide 1	Src	Others
Tyrosine Kinase Peptide 1 is a control substrate peptide for c-Src assay ^[1].

HY-P1805

Calmodulin Binding Peptide 1	Calmodulin	Neurological Disease
Calmodulin Binding Peptide 1 is a high affinity (pM) CaM-binding peptide derived from smooth muscle myosin light-chain kinase (MLCK peptide), which strongly inhibits IP3-induced Ca ²⁺ release ^[1].

HY-P1758

IFN-α Receptor Recognition Peptide 1

IRRP1
IFNAR Infection

IFN-α Receptor Recognition Peptide 1 is a peptide of IFN-α associated with receptor interactions ^[1].

IFN-α Receptor Recognition Peptide 1 IRRP1	IFNAR	Infection
IFN-α Receptor Recognition Peptide 1 is a peptide of IFN-α associated with receptor interactions ^[1].

HY-P3623

*Biotin-Glucagon-Like Peptide 1* (7-36) amide, human**	Fluorescent Dye	Others
Biotin-Glucagon-Like Peptide 1 (7-36) amide, human is a biologically active peptide. Biotin-Glucagon-Like Peptide 1 (7-36) amide, human can be used for the research of various biochemical studies.

HY-P1145

Glucagon-like peptide 1 (1-37), human

HuGLP-1
GCGR Metabolic Disease

Glucagon-like peptide 1 (1-37), human is a highly potent agonist of the GLP-1 receptor.
HY-P1145A

Glucagon-like peptide 1 (1-37), human TFA

HuGLP-1 TFA
GCGR Metabolic Disease

Glucagon-like peptide 1 (1-37), human (TFA) is a highly potent agonist of the GLP-1 receptor.

*Glucagon-like peptide 1* (1-37), human** HuGLP-1	GCGR	Metabolic Disease
Glucagon-like peptide 1 (1-37), human is a highly potent agonist of the GLP-1 receptor.

*Glucagon-like peptide 1* (1-37), human TFA** HuGLP-1 TFA	GCGR	Metabolic Disease
Glucagon-like peptide 1 (1-37), human (TFA) is a highly potent agonist of the GLP-1 receptor.

HY-P2535

*Glucagon-Like Peptide 1* (GLP-1) (7-36)-Lys (Biotin), amide, human**	GLP Receptor	Metabolic Disease
Glucagon-Like Peptide 1 (GLP-1) (7-36)-Lys (Biotin), amide, human is an C-terminal-labelled biotinylated GLP-1 (7-36) amide.

HY-P5815

GLP-1 (1-36) amide (human, rat) Glucagon-like peptide 1 (1-36) amide (human, rat)	GLP Receptor GCGR	Metabolic Disease
GLP-1 (1-36) amide (human, rat) (Glucagon-like Peptide 1 (1-36) amide (human, rat) ) is a molecular variant of glucagon-like peptide 1 (GLP-1)-(7-36) amide. GLP-1 (1-36) amide (human, rat) can stimulate [14C]aminopyrine accumulation on enzymatically dispersed enriched rat parietal cells ^[1].

HY-N2452

Cochinchinenin C	GCGR	Metabolic Disease
Cochinchinenin C is a nonpolypeptide agonist of *glucagon-like peptide-1* (GLP-1) receptor**. Cochinchinenin C can be used for the research of diabetes ^[1] .

HY-P5815A

GLP-1 (1-36) amide (human, rat) (TFA) Glucagon-like peptide 1 (1-36) amide (human, rat) (TFA)	GLP Receptor GCGR	Metabolic Disease
GLP-1 (1-36) amide (human, rat) (Glucagon-like Peptide 1 (1-36) amide (human, rat) ) TFA is a molecular variant of glucagon-like peptide 1 (GLP-1)-(7-36) amide. GLP-1 (1-36) amide (human, rat) TFA can stimulate [14C]aminopyrine accumulation on enzymatically dispersed enriched rat parietal cells ^[1].

HY-W011121

2-Oleoylglycerol	GPR119	Metabolic Disease
2-Oleoylglycerol is a dietary naturally occurring lipid. 2-Oleoylglycerol is a GPR119 agonist, with an EC₅₀ of 2.5 μM for human GPR119 in transiently transfected COS-7 cells. 2-Oleoylglycerol stimulates glucagon-like peptide-1 (GLP-1) secretion in vivo ^[1] .

HY-P3542

Des His1, Glu8 Exendin-4	GCGR	Metabolic Disease
Des His1, Glu8 Exendin-4 is a potent glucagon-like peptide-1 receptor (GLP-1-R) antagonist. Des His1, Glu8 Exendin-4 improves glucose homeostasis by regulating both insulin secretion and glucose production. Des His1, Glu8 Exendin-4 can be used for the research of type 2 diabetic and gastrointestinal ^[1].

HY-P3506

Retatrutide LY3437943	GCGR GLP Receptor	Metabolic Disease
Retatrutide (LY3437943) is a triple agonist peptide of the glucagon receptor (GCGR), glucosedependent insulinotropic polypeptide receptor (GIPR), and glucagon-like peptide-1 receptor (GLP-1R). Retatrutide binds human GCGR, GIPR, and GLP-1R with EC₅₀ values of 5.79, 0.0643 and 0.775 nM, respectively. Retatrutide can be used for the research of obesity ^[1].

HY-P3506B

Retatrutide acetate LY3437943 acetate	GCGR GLP Receptor	Metabolic Disease
Retatrutide (LY3437943) acetate is a triple agonist peptide of the glucagon receptor (GCGR), glucosedependent insulinotropic polypeptide receptor (GIPR), and glucagon-like peptide-1 receptor (GLP-1R). Retatrutide acetate inhibits human GCGR, GIPR, and GLP-1R with EC₅₀ values of 5.79, 0.0643 and 0.775 nM, respectively. Retatrutide acetate can be used for the research of obesity ^[1].

HY-P3539

Exendin-4 (3-39)	GCGR	Neurological Disease Endocrinology
Exendin-4 (3-39) is a *peptide. Exendin-4 (3-39) is a truncated form of Exendin-4 (HY-13443) that lacks the first two amino acids. Exendin-4 is a potent Glucagon-like peptide-1* receptor (GLP-1r) agonist. Exendin-4 (3-39) and Exendin-4 can be used for the research of diabetic and hypothalamic-pituitary-adrenal (HPA) axis ^[1] .

HY-P3506A

Retatrutide TFA LY3437943 TFA	GLP Receptor GCGR	Metabolic Disease
Retatrutide (LY3437943) TFA is a triple agonist peptide of the glucagon receptor (GCGR), glucosedependent insulinotropic polypeptide receptor (GIPR), and glucagon-like peptide-1 receptor (GLP-1R). Retatrutide TFA binds human GCGR, GIPR, and GLP-1R with EC₅₀ values of 5.79, 0.0643 and 0.775 nM, respectively. Retatrutide TFA can be used for the research of obesity ^[1].

HY-P0054

GLP-1(7-36), amide acetate 5+ Cited Publications Glucagon-like peptide-1 (GLP-1)(7-36), amide acetate; Human GLP-1 (7-36), amide acetate	GCGR	Metabolic Disease
GLP-1(7-36), amide acetate is a major intestinal hormone that stimulates glucose-induced insulin secretion from β cells.

HY-P0054A

GLP-1(7-36), amide Glucagon-like peptide-1 (GLP-1)(7-36), amide; Human GLP-1 (7-36), amide	GCGR	Metabolic Disease
GLP-1(7-36), amide is a physiological incretin hormone that stimulates insulin secretion.

HY-P0014

Liraglutide 10+ Cited Publications	GCGR GLP Receptor	Metabolic Disease
Liraglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist used clinically to treat type 2 diabetes mellitus.

HY-112679

GLP-1 receptor agonist 2

GCGR Others

GLP-1 receptor agonist 2 is a glucagon-like peptide-1 receptor (GLP-1R) agonist.
HY-142162

LSN3318839

GCGR Metabolic Disease

LSN3318839 is an orally efficacious positive allosteric modulator of the glucagon-like peptide-1 receptor (GLP-1R).

GLP-1 receptor agonist 2	GCGR	Others
GLP-1 receptor agonist 2 is a glucagon-like peptide-1 receptor *(GLP-1R)* agonist.

LSN3318839	GCGR	Metabolic Disease
LSN3318839 is an orally efficacious positive allosteric modulator of the glucagon-like peptide-1 receptor (GLP-1R).

HY-13443

Exendin-4 30+ Cited Publications Exenatide	GCGR	Metabolic Disease
Exendin-4 (Exenatide), a 39 amino acid peptide, is a long-acting glucagon-like peptide-1 receptor agonist with an IC₅₀ of 3.22 nM.

HY-13443A

Exendin-4 acetate 30+ Cited Publications Exenatide acetate	GCGR	Metabolic Disease
Exendin-4 acetate (Exenatide acetate), a 39 amino acid peptide, is a long-acting glucagon-like peptide-1 receptor agonist with an IC₅₀ of 3.22 nM.

HY-108795A

Albiglutide fragment TFA GLP-1-Gly8 TFA; GLP-1 (7-36) analog TFA	GLP Receptor	Metabolic Disease
Albiglutide fragment (GLP-1 (7-36) analog) TFA is an active fragment of Albiglutide (7-36) and a glucagon-like peptide-1 (GLP-1) analog (a long-acting *GLP-1* receptor agonist). Albiglutide is produced by the fusion of DPP-4 resistant GLP-1 dimer with the human albumin gene. Moreover, Albiglutide fragment TFA significantly reduces glycosylated hemoglobin (A1C) and is used in type 2 diabetes (T2D) studies ^[1] .

HY-108795

Albiglutide fragment GLP-1-Gly8; GLP-1 (7-36) analog	GLP Receptor	Metabolic Disease
Albiglutide fragment (GLP-1 (7-36) analog) is an active fragment of Albiglutide (7-36) and a glucagon-like peptide-1 (GLP-1) analog (a long-acting *GLP-1* receptor agonist). Albiglutide is produced by the fusion of DPP-4 resistant GLP-1 dimer with the human albumin gene. Moreover, Albiglutide fragment significantly reduces glycosylated hemoglobin (A1C) and is used in type 2 diabetes (T2D) studies ^[1] .

HY-P3491

Pegloxenatide PEX 168	GLP Receptor	Metabolic Disease
Pegloxenatide is a *glucagon-like peptide-1* receptor (GLP-1 RA) agonist. Pegloxenatide can be used for type 2 diabetes** research ^[1].

HY-125824

Danuglipron 1 Publications Verification PF-06882961	GCGR	Metabolic Disease
PF-06882961 is a potent, orally bioavailable agonist of the glucagon-like peptide-1 receptor (GLP-1R) ^[1] .

HY-P0119A

Lixisenatide acetate 1 Publications Verification	GCGR	Metabolic Disease
Lixisenatide acetate is a *glucagon-like peptide-1* (GLP-1) receptor** agonist that can be used in the treatment of type 2 diabetes mellitus (T2DM).

HY-114118

Semaglutide 2 Publications Verification	GCGR	Metabolic Disease
Semaglutide, a long-acting GLP-1 analogue, is a glucagon-like peptide-1 *(GLP-1)* receptor agonist. Semaglutide has the potential for type 2 diabetes treatment.

HY-P0120

Dulaglutide 1 Publications Verification LY2189265
Dulaglutide (LY2189265) is a glucagon-like peptide-1 (GLP-1) receptor agonist. Dulaglutide can be uesd for the research of type 2 diabetes (T2D) ^[1] .

HY-103546

BETP 1 Publications Verification	GCGR	Metabolic Disease
BETP is an agonist of *glucagon-like peptide-1* (GLP-1) receptor, with EC₅₀*s of 0.66 and 0.755 μM for human and rat GLP*-1 receptor, respectively.

HY-114118A

Semaglutide TFA 2 Publications Verification	GCGR	Metabolic Disease
Semaglutide TFA, a long-acting GLP-1 analogue, is a glucagon-like peptide-1 *(GLP-1)* receptor agonist. Semaglutide TFA has the potential for type 2 diabetes treatment.

HY-139276

Pal-Glu(OSu)-OH	GLP Receptor	Others
Pal-Glu(OSu)-OH is a side chain of Liraglutide. Liraglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist that can be used for type 2 diabetes mellitus research ^[1].

HY-127023

Eicosapentaenoyl serotonin EPA-5-HT	FAAH	Metabolic Disease
Eicosapentaenoyl serotonin (EPA-5-HT) is an N-acyl serotonin, a novel lipid present in the gut. Eicosapentaenoyl serotonin inhibits glucagon-like peptide-1 secretion and FAAH activity ^[1].

HY-P0054B

GLP-1(7-36), amide TFA 5+ Cited Publications Glucagon-like peptide-1 (GLP-1)(7-36), amide TFA; Human GLP-1 (7-36), amide TFA	GCGR	Metabolic Disease
GLP-1(7-36), amide TFA is a major intestinal hormone that stimulates glucose-induced insulin secretion from β cells ^[1].

HY-P4858

*C-Peptide 1* (rat)**	GSK-3	Cancer
C-Peptide 1 (rat), a peptide, is aβ-catenin/GSK-3β activator. C-Peptide 1 (rat) can regulate the Wnt/β-catenin signaling pathway. C-Peptide 1 (rat) can be used for the research of cancer ^[1].

HY-112185

Orforglipron LY3502970; GLP-1 receptor agonist 1	GCGR	Metabolic Disease
Orforglipron (LY3502970) (Compound 67) is an orally active agonist for Glucagon-like peptide-1 receptor (GLP-1R), which exhibits potency in ameliorates the type 2 diabete ^[1].

HY-129658A

TT-OAD2

GCGR Metabolic Disease

TT-OAD2 is a non-peptide glucagon-like peptide-1 (GLP-1) receptor agonist with an EC₅₀ of 5 nM. TT-OAD2 has the potential for diabetes treatment ^[1] .

TT-OAD2	GCGR	Metabolic Disease
TT-OAD2 is a non-peptide *glucagon-like peptide-1* (GLP-1) receptor agonist with an EC₅₀** of 5 nM. TT-OAD2 has the potential for diabetes treatment ^[1] .

HY-N0630

Shanzhiside methyl ester	GCGR	Neurological Disease
Shanzhiside methy lester is isolated from lamiophlomis rotata. Shanzhiside methyl ester is a small molecule *glucagon-like peptide-1* (GLP-1) receptor** agonist and has the ability to induce anti-allodynic tolerance ^[1].

HY-135195

Boc5	GLP Receptor	Metabolic Disease
Boc5 is a non-peptidic *glucagon-like peptide-1* receptor** agonist. Boc5 causes sustained glycemic control and weight loss in diabetic mice. Boc5 can be used in research of diabetic ^[1] .

HY-129658

TT-OAD2 free base	GCGR	Metabolic Disease
TT-OAD2 free base is a non-peptide *glucagon-like peptide-1* (GLP-1) receptor agonist with an EC₅₀** of 5 nM. TT-OAD2 free base has the potential for diabetes treatment ^[1] .

HY-143312

V-0219	GLP Receptor	Metabolic Disease
V-0219 (Compound 9) is an orally active, positive allosteric modulator (PAM) of the glucagon-like peptide-1 receptor (GLP-1R). V-0219 can be used for obesity-associated diabetes research ^[1].

HY-143312A

V-0219 hydrochloride	GLP Receptor	Metabolic Disease
V-0219 hydrochloride (Compound 9) is an orally active, positive allosteric modulator (PAM) of the glucagon-like peptide-1 receptor (GLP-1R). V-0219 hydrochloride can be used for obesity-associated diabetes research ^[1].

HY-156968

GLP-1 receptor agonist 14	GLP Receptor	Metabolic Disease
GLP-1 receptor agonist 14 (compound 73) is a potent agonist of glucagon-like peptide-1 (GLP-1). GLP-1 receptor agonist 14 plays an important role in diabetes or other metabolic disorders ^[1].

HY-147625

GLP-1R agonist 12	GLP Receptor	Metabolic Disease
GLP-1R agonist 12 (Compound 123) is an agonist of glucagon-like peptide-1 receptors (GLP-1R). GLP-1R agonist 12 can be used for diabetes research ^[1].

HY-P0014S2

Liraglutide-13C6,15N TFA	Isotope-Labeled Compounds	Others
Liraglutide- ¹³C₆, ¹⁵N (TFA)is the ¹³C and ¹⁵N labeledLiraglutide(HY-P0014). Liraglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist used clinically to treat type 2 diabetes mellitus ^[1].

HY-P0014S1

Liraglutide-13C5,15N TFA	Isotope-Labeled Compounds	Others
Liraglutide- ¹³C₅, ¹⁵N (tetraTFA)is the ¹³C and ¹⁵N labeledLiraglutide(HY-P0014) ^[1]. Liraglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist used clinically to treat type 2 diabetes mellitus .

HY-P1731B

Tirzepatide hydrochloride 3 Publications Verification LY3298176 hydrochloride	GLP Receptor	Neurological Disease Metabolic Disease Cancer
Tirzepatide hydrochloride (LY3298176 hydrochloride) is a glucose-dependent insulin nutritive polypeptide (GIP) and glucagon-like peptide-1 *(GLP-1)* receptor dual agonist. Tirzepatide hydrochloride has neuroprotective effects and can be used in the study of type 2 diabetes, diabetes-related neuropathy and obesity ^[1] .

HY-103433

K579	Dipeptidyl Peptidase	Metabolic Disease
K579 is a potent and orally active dipeptidyl peptidase IV inhibitor. K579 inhibits the blood glucose elevation. K579 increases the plasma insulin and active forms of glucagon-like peptide-1 (GLP-1). K579 has the potential for the research of diabetic ^[1].

Cat. No.	Product Name	Type

HY-P1363F3

5-FAM-β-Amyloid (1-42), human Tris 5-FAM-Amyloid β-peptide (1-42) (human) Tris	Fluorescent Dyes/Probes
5-FAM-β-Amyloid (1-42), human (5-FAM-Amyloid β-peptide (1-42) (human) TFA is a5-FAM labeled β-Amyloid (1-42), human (TFA) (HY-P1363).

HY-D1423

Dibromobimane

Fluorescent Dyes/Probes

Dibromobimane is a thiol-selective fluorescent imaging agent. Dibromobimane is used to crosslink cysteine- and homocysteine-containing peptides .

HY-W039519

7-Methoxycoumarin-3-carboxylic acid	Fluorescent Dyes/Probes
7-Methoxycoumarin-3-carboxylic acid is a fluorescent dye with an excitation peak at 355 nm and an emission peak at 405 nm. 7-Methoxycoumarin-3-carboxylic acid can be used to label peptide .

HY-D1592

BODIPY TMR C5-maleimide	Fluorescent Dyes/Probes
BODIPY TMR C5-maleimide is a fluorescent dye. BODIPY TMR C5-maleimide is a high quantum yield fluorophore which can be coupled with peptides .

Cat. No.	Product Name	Type

HY-D0878

TAPSO	Biochemical Assay Reagents
TAPSO is a common biological buffer, a pH stabilization reagent, with effective pH ranging from 7-8, and pKa values ranging from 7.5–9.0. TAPSO contains Tris groups and exhibits quite reactive activity with zwitterionic glycine peptides .

HY-134393B

6-Me-ATP trisodium N6-Methyl-ATP trisodium	Gene Sequencing and Synthesis
6-Me-ATP (N6-Methyl-ATP) trisodium is a N ⁶-modified ATP derivative. 6-Me-ATP trisodium shows excellent binding affinity to GSK3, serving as the phosphate group donor for GSK3β-catalyzed phosphorylation of its substrate peptide .

HY-126437A

Poly-L-lysine hydrochloride

Drug Delivery

Poly-L-lysine hydrochloride is a nonspecific attachment factor for cells useful in promoting cell adhesion to solid substrates by enhancing electrostatic interaction between negatively charged ions of the cell membrane and the culture surface. Poly-L-lysine hydrochloride is a strong-attraction regulator that promotes liquid-liquid phase separation (LLPS) at low concentrations but suppresses LLPS at high concentrations. Antibacterial cationic peptide. .

Cat. No.	Product Name	Target	Research Area

HY-P0122B

*iRGD peptide 1* TFA**	Peptides	Cancer
iRGD peptide 1 TFA is the prototypic tumor-specific tissue-penetrating peptide, which delivers agents deep into extravascular tumor tissue. iRGD peptide 1 TFA has anti-metastatic activity ^[1].

HY-P3756

EPO mimetic peptide-1 EMP-1	Peptides	Inflammation/Immunology
EPO mimetic peptide-1 (EMP-1), a 20 amino acid peptide. EPO mimetic peptide-1 stimulates cell proliferation, affects cell cycle and induces the production of reticulocytes in vivo ^[1].

HY-P3712

Cardioexcitatory peptide 1	Peptides	Cardiovascular Disease Neurological Disease
Cardioexcitatory peptide 1 is a cardioexcitatory neuropeptide, can be isolated from Achatina atria. Cardioexcitatory peptide 1 has potent cardio-excitatory action on the hearts and also modifies the motility of muscular tissues and neural activities ^[1].

HY-P3414

Proteasome-activating peptide 1	Peptides	Neurological Disease
Proteasome-activating peptide 1 is a peptide, which increases the chymotrypsin-like proteasomal catalytic activity and, consequently, proteolytic rates both in vitro and in culture. Proteasome-activating peptide 1 prevents protein aggregation in a cellular model of amyotrophic lateral sclerosis ^[1].

HY-P2547

Tyrosine Kinase Peptide 1

Src Others

Tyrosine Kinase Peptide 1 is a control substrate peptide for c-Src assay ^[1].

HY-P3414A

*Proteasome-activating peptide 1* TFA** 1 Publications Verification	Proteasome	Neurological Disease
Proteasome-activating peptide 1 TFA is a peptide and a potent proteasome activator. Proteasome-activating peptide 1 TFA increases the chymotrypsin-like proteasomal catalytic activity and, consequently, proteolytic rates both in vitro and in culture. Proteasome-activating peptide 1 TFA prevents protein aggregation in a cellular model of amyotrophic lateral sclerosis ^[1].

HY-P1805

Calmodulin Binding Peptide 1	Calmodulin	Neurological Disease
Calmodulin Binding Peptide 1 is a high affinity (pM) CaM-binding peptide derived from smooth muscle myosin light-chain kinase (MLCK peptide), which strongly inhibits IP3-induced Ca ²⁺ release ^[1].

HY-P0277

Carcinoembryonic antigen peptide 1

CAP1; CEA peptide
Peptides Cancer

Carcinoembryonic antigen peptide 1 (CAP1) is a tumor marker in lung cancer.
HY-P1758

IFN-α Receptor Recognition Peptide 1

IRRP1
IFNAR Infection

IFN-α Receptor Recognition Peptide 1 is a peptide of IFN-α associated with receptor interactions ^[1].

HY-P3623

*Biotin-Glucagon-Like Peptide 1* (7-36) amide, human**	Fluorescent Dye	Others
Biotin-Glucagon-Like Peptide 1 (7-36) amide, human is a biologically active peptide. Biotin-Glucagon-Like Peptide 1 (7-36) amide, human can be used for the research of various biochemical studies.

HY-P1145

Glucagon-like peptide 1 (1-37), human

HuGLP-1
GCGR Metabolic Disease

Glucagon-like peptide 1 (1-37), human is a highly potent agonist of the GLP-1 receptor.
HY-P1145A

Glucagon-like peptide 1 (1-37), human TFA

HuGLP-1 TFA
GCGR Metabolic Disease

Glucagon-like peptide 1 (1-37), human (TFA) is a highly potent agonist of the GLP-1 receptor.

HY-P2535

*Glucagon-Like Peptide 1* (GLP-1) (7-36)-Lys (Biotin), amide, human**	GLP Receptor	Metabolic Disease
Glucagon-Like Peptide 1 (GLP-1) (7-36)-Lys (Biotin), amide, human is an C-terminal-labelled biotinylated GLP-1 (7-36) amide.

HY-P5815

GLP-1 (1-36) amide (human, rat) Glucagon-like peptide 1 (1-36) amide (human, rat)	GLP Receptor GCGR	Metabolic Disease
GLP-1 (1-36) amide (human, rat) (Glucagon-like Peptide 1 (1-36) amide (human, rat) ) is a molecular variant of glucagon-like peptide 1 (GLP-1)-(7-36) amide. GLP-1 (1-36) amide (human, rat) can stimulate [14C]aminopyrine accumulation on enzymatically dispersed enriched rat parietal cells ^[1].

HY-P5815A

GLP-1 (1-36) amide (human, rat) (TFA) Glucagon-like peptide 1 (1-36) amide (human, rat) (TFA)	GLP Receptor GCGR	Metabolic Disease
GLP-1 (1-36) amide (human, rat) (Glucagon-like Peptide 1 (1-36) amide (human, rat) ) TFA is a molecular variant of glucagon-like peptide 1 (GLP-1)-(7-36) amide. GLP-1 (1-36) amide (human, rat) TFA can stimulate [14C]aminopyrine accumulation on enzymatically dispersed enriched rat parietal cells ^[1].

HY-P3542

Des His1, Glu8 Exendin-4	GCGR	Metabolic Disease
Des His1, Glu8 Exendin-4 is a potent glucagon-like peptide-1 receptor (GLP-1-R) antagonist. Des His1, Glu8 Exendin-4 improves glucose homeostasis by regulating both insulin secretion and glucose production. Des His1, Glu8 Exendin-4 can be used for the research of type 2 diabetic and gastrointestinal ^[1].

HY-P3506

Retatrutide LY3437943	GCGR GLP Receptor	Metabolic Disease
Retatrutide (LY3437943) is a triple agonist peptide of the glucagon receptor (GCGR), glucosedependent insulinotropic polypeptide receptor (GIPR), and glucagon-like peptide-1 receptor (GLP-1R). Retatrutide binds human GCGR, GIPR, and GLP-1R with EC₅₀ values of 5.79, 0.0643 and 0.775 nM, respectively. Retatrutide can be used for the research of obesity ^[1].

HY-P3506B

Retatrutide acetate LY3437943 acetate	GCGR GLP Receptor	Metabolic Disease
Retatrutide (LY3437943) acetate is a triple agonist peptide of the glucagon receptor (GCGR), glucosedependent insulinotropic polypeptide receptor (GIPR), and glucagon-like peptide-1 receptor (GLP-1R). Retatrutide acetate inhibits human GCGR, GIPR, and GLP-1R with EC₅₀ values of 5.79, 0.0643 and 0.775 nM, respectively. Retatrutide acetate can be used for the research of obesity ^[1].

HY-P3539

Exendin-4 (3-39)	GCGR	Neurological Disease Endocrinology
Exendin-4 (3-39) is a *peptide. Exendin-4 (3-39) is a truncated form of Exendin-4 (HY-13443) that lacks the first two amino acids. Exendin-4 is a potent Glucagon-like peptide-1* receptor (GLP-1r) agonist. Exendin-4 (3-39) and Exendin-4 can be used for the research of diabetic and hypothalamic-pituitary-adrenal (HPA) axis ^[1] .

HY-P3506A

Retatrutide TFA LY3437943 TFA	GLP Receptor GCGR	Metabolic Disease
Retatrutide (LY3437943) TFA is a triple agonist peptide of the glucagon receptor (GCGR), glucosedependent insulinotropic polypeptide receptor (GIPR), and glucagon-like peptide-1 receptor (GLP-1R). Retatrutide TFA binds human GCGR, GIPR, and GLP-1R with EC₅₀ values of 5.79, 0.0643 and 0.775 nM, respectively. Retatrutide TFA can be used for the research of obesity ^[1].

HY-P0054

GLP-1(7-36), amide acetate 5+ Cited Publications Glucagon-like peptide-1 (GLP-1)(7-36), amide acetate; Human GLP-1 (7-36), amide acetate	GCGR	Metabolic Disease
GLP-1(7-36), amide acetate is a major intestinal hormone that stimulates glucose-induced insulin secretion from β cells.

HY-P0054A

GLP-1(7-36), amide Glucagon-like peptide-1 (GLP-1)(7-36), amide; Human GLP-1 (7-36), amide	GCGR	Metabolic Disease
GLP-1(7-36), amide is a physiological incretin hormone that stimulates insulin secretion.

HY-P0014

Liraglutide 10+ Cited Publications	GCGR GLP Receptor	Metabolic Disease
Liraglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist used clinically to treat type 2 diabetes mellitus.

HY-13443

Exendin-4 Maximum Cited Publications 34 Publications Verification Exenatide	GCGR	Metabolic Disease
Exendin-4 (Exenatide), a 39 amino acid peptide, is a long-acting glucagon-like peptide-1 receptor agonist with an IC₅₀ of 3.22 nM.

HY-13443A

Exendin-4 acetate Maximum Cited Publications 34 Publications Verification Exenatide acetate	GCGR	Metabolic Disease
Exendin-4 acetate (Exenatide acetate), a 39 amino acid peptide, is a long-acting glucagon-like peptide-1 receptor agonist with an IC₅₀ of 3.22 nM.

HY-108795A

Albiglutide fragment TFA GLP-1-Gly8 TFA; GLP-1 (7-36) analog TFA	GLP Receptor	Metabolic Disease
Albiglutide fragment (GLP-1 (7-36) analog) TFA is an active fragment of Albiglutide (7-36) and a glucagon-like peptide-1 (GLP-1) analog (a long-acting *GLP-1* receptor agonist). Albiglutide is produced by the fusion of DPP-4 resistant GLP-1 dimer with the human albumin gene. Moreover, Albiglutide fragment TFA significantly reduces glycosylated hemoglobin (A1C) and is used in type 2 diabetes (T2D) studies ^[1] .

HY-108795

Albiglutide fragment GLP-1-Gly8; GLP-1 (7-36) analog	GLP Receptor	Metabolic Disease
Albiglutide fragment (GLP-1 (7-36) analog) is an active fragment of Albiglutide (7-36) and a glucagon-like peptide-1 (GLP-1) analog (a long-acting *GLP-1* receptor agonist). Albiglutide is produced by the fusion of DPP-4 resistant GLP-1 dimer with the human albumin gene. Moreover, Albiglutide fragment significantly reduces glycosylated hemoglobin (A1C) and is used in type 2 diabetes (T2D) studies ^[1] .

HY-P3491

Pegloxenatide

PEX 168
GLP Receptor Metabolic Disease

Pegloxenatide is a glucagon-like peptide-1 receptor (GLP-1 RA) agonist. Pegloxenatide can be used for type 2 diabetes research ^[1].

HY-P0119A

Lixisenatide acetate 1 Publications Verification	GCGR	Metabolic Disease
Lixisenatide acetate is a *glucagon-like peptide-1* (GLP-1) receptor** agonist that can be used in the treatment of type 2 diabetes mellitus (T2DM).

HY-P4407

(D-Asn28)-Exenatide

Peptides Metabolic Disease

(D-Asn28)-Exenatide is an Exenatide (HY-13443) impurity. Exenatide is a long-acting glucagon-like peptide-1 receptor agonist ^[1].
HY-P4410

(D-Asp28)-Exenatide

Peptides Metabolic Disease

(D-Asp28)-Exenatide is an Exenatide (HY-13443) impurity. Exenatide is a long-acting glucagon-like peptide-1 receptor agonist ^[1].

HY-114118

Semaglutide 2 Publications Verification	GCGR	Metabolic Disease
Semaglutide, a long-acting GLP-1 analogue, is a glucagon-like peptide-1 *(GLP-1)* receptor agonist. Semaglutide has the potential for type 2 diabetes treatment.

HY-114118A

Semaglutide TFA 2 Publications Verification	GCGR	Metabolic Disease
Semaglutide TFA, a long-acting GLP-1 analogue, is a glucagon-like peptide-1 *(GLP-1)* receptor agonist. Semaglutide TFA has the potential for type 2 diabetes treatment.

HY-P0054B

GLP-1(7-36), amide TFA 5+ Cited Publications Glucagon-like peptide-1 (GLP-1)(7-36), amide TFA; Human GLP-1 (7-36), amide TFA	GCGR	Metabolic Disease
GLP-1(7-36), amide TFA is a major intestinal hormone that stimulates glucose-induced insulin secretion from β cells ^[1].

HY-P4858

*C-Peptide 1* (rat)**	GSK-3	Cancer
C-Peptide 1 (rat), a peptide, is aβ-catenin/GSK-3β activator. C-Peptide 1 (rat) can regulate the Wnt/β-catenin signaling pathway. C-Peptide 1 (rat) can be used for the research of cancer ^[1].

HY-P0014S2

Liraglutide-13C6,15N TFA	Isotope-Labeled Compounds	Others
Liraglutide- ¹³C₆, ¹⁵N (TFA)is the ¹³C and ¹⁵N labeledLiraglutide(HY-P0014). Liraglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist used clinically to treat type 2 diabetes mellitus ^[1].

HY-P0014S1

Liraglutide-13C5,15N TFA	Isotope-Labeled Compounds	Others
Liraglutide- ¹³C₅, ¹⁵N (tetraTFA)is the ¹³C and ¹⁵N labeledLiraglutide(HY-P0014) ^[1]. Liraglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist used clinically to treat type 2 diabetes mellitus .

HY-P1731B

Tirzepatide hydrochloride 3 Publications Verification LY3298176 hydrochloride	GLP Receptor	Neurological Disease Metabolic Disease Cancer
Tirzepatide hydrochloride (LY3298176 hydrochloride) is a glucose-dependent insulin nutritive polypeptide (GIP) and glucagon-like peptide-1 *(GLP-1)* receptor dual agonist. Tirzepatide hydrochloride has neuroprotective effects and can be used in the study of type 2 diabetes, diabetes-related neuropathy and obesity ^[1] .

HY-P1731

Tirzepatide 3 Publications Verification LY3298176	GLP Receptor	Neurological Disease Metabolic Disease Cancer
Tirzepatide (LY3298176) is a glucose-dependent insulin nutritive polypeptide (GIP) and glucagon-like peptide-1 *(GLP-1)* receptor dual agonist. Tirzepatide has neuroprotective effects and can be used in the study of type 2 diabetes, diabetes-related neuropathy and obesity ^[1] .

HY-P1731A

Tirzepatide TFA LY3298176 TFA	GLP Receptor	Neurological Disease Metabolic Disease Cancer
Tirzepatide TFA (LY3298176 hydrochloride) is a glucose-dependent insulin nutritive polypeptide (GIP) and glucagon-like peptide-1 *(GLP-1)* receptor dual agonist. Tirzepatide TFA has neuroprotective effects and can be used in the study of type 2 diabetes, diabetes-related neuropathy and obesity ^[1] .

HY-P3291

Dapiglutide ZP7570	GCGR	Metabolic Disease
Dapiglutide (ZP7570) is a long-acting *glucagon-like peptide-1* receptor 1R (GLP-1R)/Glucagon-like peptide-2 receptor (GLP-2R)** dual agonist. Dapiglutide can be used for short bowel syndrome (SBS) research ^[1].

HY-P10018

Bamadutide SAR425899	GLP Receptor GCGR	Metabolic Disease
Bamadutide (SAR425899) is a potent dual *glucagon-like peptide-1* receptor/glucagon receptor** agonist. Bamadutide (SAR425899) improves postprandial glucose control by significantly enhancing β-cell function and slowing glucose absorption rate in vivo. Bamadutide (SAR425899)can be used for type 2 diabetes research ^[1].

HY-P4923

Tau Peptide (1-16) (human)

Tau Protein Neurological Disease

Tau Peptide (1-16) (human) is aTau fragment.

HY-P1520

*Prolactin Releasing Peptide (1-31), human*	GnRH Receptor	Neurological Disease
Prolactin Releasing Peptide (1-31), human is a high affinity GPR10 ligand that cause the release of the prolactin. Prolactin Releasing Peptide (1-31) binds to GPR10 for human and rats with K_i values of 1.03 nM and 0.33 nM, respectively. Prolactin Releasing Peptide (1-31) can be used for the research of the hypothalamo-pituitary axis ^[1] .

HY-P1520A

*Prolactin Releasing Peptide (1-31), human acetate*	GnRH Receptor	Neurological Disease
Prolactin Releasing Peptide (1-31), human (acetate) is a high affinity GPR10 ligand that causes the release of the prolactin. Prolactin Releasing Peptide (1-31) binds to GPR10 for human and rats with K_i values of 1.03 nM and 0.33 nM, respectively. Prolactin Releasing Peptide (1-31) can be used for the research of the hypothalamo-pituitary axis ^[1] .

HY-P2231A

Cotadutide acetate MEDI0382 acetate	GCGR	Metabolic Disease
Cotadutide (MEDI0382) acetate is a potent dual agonist of glucagon-like peptide-1 (GLP-1) and GCGR with EC₅₀ values of 6.9 pM and 10.2 pM, respectively. Cotadutide acetate exhibits ability to facilitate both weight loss and glycaemic control, and alleviate fibrosis. Cotadutide acetate can be used in the research of obesity and type 2 diabetes (T2D) ^[1] .

HY-P2231

Cotadutide MEDI0382	GCGR	Metabolic Disease
Cotadutide (MEDI0382) is a potent dual agonist of glucagon-like peptide-1 (GLP-1) and GCGR with EC₅₀ values of 6.9 pM and 10.2 pM, respectively. Cotadutide exhibits ability to facilitate both weight loss and glycaemic control, and alleviate fibrosis. Cotadutide can be used in the research of obesity and type 2 diabetes (T2D) ^[1] .

HY-P4689

*Prolactin-Releasing Peptide (1-31) (rat)*	Peptides	Metabolic Disease
Prolactin-Releasing Peptide (1-31) (rat) is a UHR-1/GRP10 receptor ligand. Prolactin-Releasing Peptide (1-31) (rat) reduces fasting-induced food intake, increases plasma levels of LH, FSH, and testosterone in rats ^[1] .

HY-P3946

Prolactin-Releasing Peptide (1-31), bovine

Peptides Endocrinology

Prolactin-Releasing Peptide (1-31), bovine is a fragment of the prolactin releasing peptide (PrRP) ^[1].

HY-P1230

HAEGT	Dipeptidyl Peptidase GLP Receptor	Metabolic Disease
HAEGT is the first N-terminal 1-5 residues of glucagon like peptide-1 (GLP-1) peptide, and the sequence is His-Ala-Glu-Gly-Thr. HAEGT acts as a competitive substrate for probing prime substrate binding sites of human dipeptidyl peptidase-IV (DPP-IV) 1, in which the N-terminal His-Ala is catalyzed cleavage by DPP-IV. HAEGT can be used in the research of diabetes, obesity ^[1].

Cat. No.	Product Name	Target	Research Area

HY-P990013

Gulgafafusp alfa

GCGR Metabolic Disease

Gulgafafusp alfa is a human IgG2κ antibody targeting the glucagon-like peptide 1 receptor GLP1R ^[1].

Cat. No.	Product Name	Category	Target	Chemical Structure

HY-P0277

Carcinoembryonic antigen peptide 1 CAP1; CEA peptide	Structural Classification Natural Products Classification of Application Fields Source classification Endogenous metabolite Disease Research Fields Cancer	Others
Carcinoembryonic antigen peptide 1 (CAP1) is a tumor marker in lung cancer.

HY-W011121

2-Oleoylglycerol	Natural Products Human Gut Microbiota Metabolites Microorganisms Classification of Application Fields Source classification Metabolic Disease Endogenous metabolite Disease Research Fields	GPR119
2-Oleoylglycerol is a dietary naturally occurring lipid. 2-Oleoylglycerol is a GPR119 agonist, with an EC₅₀ of 2.5 μM for human GPR119 in transiently transfected COS-7 cells. 2-Oleoylglycerol stimulates glucagon-like peptide-1 (GLP-1) secretion in vivo ^[1] .

HY-N0630

Shanzhiside methyl ester	Iridoids Terpenoids Labiatae Source classification Plants Helenium radiatum (Less.) Bierner	GCGR
Shanzhiside methy lester is isolated from lamiophlomis rotata. Shanzhiside methyl ester is a small molecule *glucagon-like peptide-1* (GLP-1) receptor** agonist and has the ability to induce anti-allodynic tolerance ^[1].

HY-N2452

Cochinchinenin C	other families Classification of Application Fields Source classification Phenols Polyphenols Metabolic Disease Plants Disease Research Fields	GCGR
Cochinchinenin C is a nonpolypeptide agonist of *glucagon-like peptide-1* (GLP-1) receptor**. Cochinchinenin C can be used for the research of diabetes ^[1] .

HY-119640

Aspercolorin	Alkaloids Microorganisms Classification of Application Fields Cyclopeptides Source classification Other Diseases Pyridine Alkaloids Disease Research Fields	Endogenous Metabolite
Aspercolorin, a secondary metabolite, is a cyclic peptide .

HY-N12513

Cyclo(L-Phe-trans-4-OH-L-Pro)

Structural Classification Natural Products Microorganisms Source classification

Fungal

Cyclo(L-Phe-trans-4-OH-L-Pro) is an antifungal peptides .

Species:	Human (7) Mouse (2)
Tag:	His (5) SUMO (2) Myc (1) GST (3) Fc (1)
Source:	HEK293 (3) E. coli Cell-free (1) P. pastoris (1) E. coli (4)

Cat. No.	Compare	Product Name	Species	Source

HY-P70352

	GLP1R Protein, Human (HEK293, Fc) rHuGlucagon-like peptide 1 receptor/GLP1R, Fc; Glucagon-like peptide 1 receptor; GLP-1 receptor; GLP-1-R	Human	HEK293
	The GLP1R protein is a G protein-coupled receptor for glucagon-like peptide 1 (GLP-1), which upon ligand binding activates adenylyl cyclase and increases cAMP levels. This interaction critically regulates insulin secretion, affecting cellular responses and metabolic processes associated with GLP-1 signaling. GLP1R Protein, Human (HEK293, Fc) is the recombinant human-derived GLP1R protein, expressed by HEK293 , with C-hFc labeled tag. The total length of GLP1R Protein, Human (HEK293, Fc) is 122 a.a., with molecular weight of 50-70 kDa.

HY-P70239

	GLP-1/GCG Protein, Human (HEK293, His) 1 Publications Verification rHuPro-glucagon/GCG, His ; Glucagon; Glicentin; Glicentin-Related Polypeptide; GRPP; Oxyntomodulin; OXM; OXY; Glucagon; Glucagon-Like peptide 1; GLP-1; Incretin Hormone; Glucagon-like peptide 1; GLP-1; Glucagon-Like peptide 2; GLP-2; GCG	Human	HEK293
	GLP-1/GCG proteins play a key role in glucose metabolism and influence blood glucose levels. As a counterregulatory hormone to insulin, it increases gluconeogenesis and stimulates glucose-dependent insulin release, thereby affecting insulin secretion. GLP-1/GCG Protein, Human (HEK293, His) is the recombinant human-derived GLP-1/GCG protein, expressed by HEK293 , with C-6*His labeled tag. The total length of GLP-1/GCG Protein, Human (HEK293, His) is 160 a.a., with molecular weight of ~19.0 kDa.

HY-P700468

	GLP1R Protein, Human (HEK293, N-His, C-Myc) rHuGlucagon-like peptide 1 receptor/GLP1R, Fc; Glucagon-like peptide 1 receptor; GLP-1 receptor; GLP-1-R	Human	HEK293
	The GLP1R protein is a G protein-coupled receptor for glucagon-like peptide 1 (GLP-1), which upon ligand binding activates adenylyl cyclase and increases cAMP levels. This interaction critically regulates insulin secretion, affecting cellular responses and metabolic processes associated with GLP-1 signaling. GLP1R Protein, Human (HEK293, N-His, C-Myc) is the recombinant human-derived GLP1R protein, expressed by HEK293 , with C-Myc, N-10*His labeled tag. The total length of GLP1R Protein, Human (HEK293, N-His, C-Myc) is 122 a.a., with molecular weight of 19.3 kDa.

HY-P702340

	KCNE2 Protein, Human (Cell-Free, His) Potassium voltage-gated channel subfamily E member 2; MinK-related peptide 1; Minimum potassium ion channel-related peptide 1; Potassium channel subunit beta MiRP1	Human	E. coli Cell-free
	The KCNE2 protein acts as an auxiliary subunit in voltage-gated potassium channels, affecting gating kinetics and channel stability. It regulates KCNB1, affects delayed rectifier voltage-dependent potassium channels, and cooperates with KCNH2/HERG to form the rapidly activating component of cardiac delayed rectifier potassium current (IKr). KCNE2 Protein, Human (Cell-Free, His) is the recombinant human-derived KCNE2 protein, expressed by E. coli Cell-free , with N-10*His labeled tag. The total length of KCNE2 Protein, Human (Cell-Free, His) is 123 a.a., with molecular weight of 17.3 kDa.

HY-P70400

	Hepcidin/HAMP Protein, Human (GST) rHuHepcidin/HAMP, GST; Liver-expressed antimicrobial peptide 1; Putative liver tumor regressor; HEPC; LEAP1	Human	E. coli
	The hepcidin/HAMP protein is a liver-produced hormone that is a major circulating regulator of iron absorption and distribution. It promotes endocytosis and degradation of ferroportin/SLC40A1, retaining iron within cells and reducing plasma iron flux. Hepcidin/HAMP Protein, Human (GST) is the recombinant human-derived Hepcidin/HAMP protein, expressed by E. coli , with N-GST labeled tag. The total length of Hepcidin/HAMP Protein, Human (GST) is 25 a.a., with molecular weight of 28-30 kDa.

HY-P700634

	Hepcidin/HAMP Protein, Mouse (GST) 1 Publications Verification rHuHepcidin/HAMP, GST; Liver-expressed antimicrobial peptide 1; Putative liver tumor regressor; HEPC; LEAP1	Mouse	E. coli
	The hepcidin/HAMP protein is a liver-produced hormone that is a major regulator of iron absorption and distribution. It promotes endocytosis and degradation of SLC40A1, retaining iron within cells and reducing plasma iron flux. Hepcidin/HAMP Protein, Mouse (GST) is the recombinant mouse-derived Hepcidin/HAMP protein, expressed by E. coli , with N-GST labeled tag. The total length of Hepcidin/HAMP Protein, Mouse (GST) is 25 a.a., with molecular weight of 29.4 kDa.

HY-P71702

	Calcitonin/CALCA Protein, Human (GST) CALCA; CALC1Calcitonin gene-related peptide 1; Alpha-type CGRP; Calcitonin gene-related peptide I; CGRP-I	Human	E. coli
	Calcitonin/CALCA protein acts as a vasodilator, dilating different blood vessels, including coronary, cerebral, and systemic vessels. Its presence in the central nervous system suggests its potential role as a neurotransmitter or neuromodulator. Calcitonin/CALCA Protein, Human (GST) is the recombinant human-derived Calcitonin/CALCA protein, expressed by E. coli , with N-GST labeled tag. The total length of Calcitonin/CALCA Protein, Human (GST) is 36 a.a., with molecular weight of ~30.6 kDa.

HY-P72206

	GLP1R Protein, Mouse (His-SUMO) Glp1r; Glucagon-like peptide 1 receptor; GLP-1 receptor; GLP-1-R; GLP-1R	Mouse	E. coli
	GLP1R protein, a G-protein coupled receptor, binds to GLP-1, activating adenylyl cyclase and increasing intracellular cAMP levels. This interaction regulates insulin secretion and maintains glucose homeostasis. GLP1R can also form dimers with GIPR, suggesting complex regulatory mechanisms and interactions with other receptors. GLP1R Protein, Mouse (His-SUMO) is the recombinant mouse-derived GLP1R protein, expressed by E. coli , with N-6*His, N-SUMO labeled tag. The total length of GLP1R Protein, Mouse (His-SUMO) is 124 a.a., with molecular weight of ~30.4 kDa.

HY-P700614

	Calcitonin/CALCA Protein, Human (P. pastoris, His-SUMO) CALCA; CALC1Calcitonin gene-related peptide 1; Alpha-type CGRP; Calcitonin gene-related peptide I; CGRP-I	Human	P. pastoris
	Calcitonin/CALCA protein acts as a vasodilator, dilating different blood vessels, including coronary, cerebral, and systemic vessels. Its presence in the central nervous system suggests its potential role as a neurotransmitter or neuromodulator. Calcitonin/CALCA Protein, Human (P. pastoris, His-SUMO) is the recombinant human-derived Calcitonin/CALCA protein, expressed by P. pastoris , with N-SUMO, N-6*His labeled tag. The total length of Calcitonin/CALCA Protein, Human (P. pastoris, His-SUMO) is 37 a.a., with molecular weight of 22 kDa.

Cat. No.	Product Name	Chemical Structure

HY-P0014S2

Liraglutide-13C6,15N TFA
Liraglutide- ¹³C₆, ¹⁵N (TFA)is the ¹³C and ¹⁵N labeledLiraglutide(HY-P0014). Liraglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist used clinically to treat type 2 diabetes mellitus ^[1].

HY-P0014S1

Liraglutide-13C5,15N TFA
Liraglutide- ¹³C₅, ¹⁵N (tetraTFA)is the ¹³C and ¹⁵N labeledLiraglutide(HY-P0014) ^[1]. Liraglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist used clinically to treat type 2 diabetes mellitus .

HY-P1363S

β-Amyloid-15N (1-42), human TFA
β-Amyloid- ¹⁵N (1-42), human (TFA) is the ¹⁵N-labledβ-Amyloid (1-42) (TFA). β-Amyloid (1-42), human TFA (Amyloid β-Peptide (1-42) (human) TFA) is a 42-amino acid peptide which plays a key role in the pathogenesis of Alzheimer disease[1].

HY-10235S

Telaprevir-d4
Telaprevir-d₄ is the deuterium labeled Telaprevir. Telaprevir (VX-950) is a highly selective, reversible, and potent peptidomimetic inhibitor of the HCV NS3-4A protease, the steady-state inhibitory constant (Ki) of Telaprevir is 7 nM against a genotype 1 (H strain) NS3 protease domain plus a NS4A cofactor peptide[1][2][3]. Telaprevir inhibits SARS-CoV-2 3CLpro activity[4].

Cat. No.	Product Name	Application	Reactivity

HY-P81160

GLP-1R Antibody Glucagon like peptide-1 receptor; GLP 1 R; GLP 1 receptor; GLP 1R; Glp1r; GLP; glp1r; Glucagon like peptide 1 receptor; RATGL1RCP; Glip; MGC138331; GLP-1-R; GLP1R_HUMAN; Glucagon-like peptide 1 receptor; GLP-1 receptor; GLP-1-R; GLP-1R; Precursor.	WB; ELISA; IHC-P; IHC-F; Flow-Cyt; ICC; IF	Human, Mouse, Rat(predicted: Dog)
GLP-1R Antibody is an unconjugated, approximately 51 kDa, rabbit-derived, anti-GLP-1R polyclonal antibody. GLP-1R Antibody can be used for: WB, ELISA, IHC-P, IHC-F, Flow-Cyt, ICC, IF expriments in human, mouse, rat, and predicted: dog background without labeling.

Cat. No.	Product Name		Classification

HY-151696

TCO-PEG3-maleimide		TCO
TCO-PEG3-maleimide (TCO-PEG3-NEM) is a click chemistry reagent. TCO-PEG3-maleimide efficiently binds TCO (trans-cyclooctene) moiety to thiol-containing molecules (such as antibodies, cysteine-containing peptides) .


Products	In-stock - + Add to Cart
Cat. No.
Species
Source
Tag
Accession
Gene ID
Molecular Weight
Purity
Endotoxin Level
Biological Activity
Appearance
Formulation
Storage & Stability
Shipping
Free Sample	Yes No
Size	* This product has been "discontinued". Optimized version of product available: / In-stock - + Add to Cart Get quote

MCE Japan Authorized Agent ナミキ商事株式会社コスモ・バイオ株式会社
Salutation			Country or Region *
Applicant Name *			Organization Name *
Department *
Email Address *			Product Name *
Cat. No.			Requested quantity *
Phone Number *
Remarks

Inhibitors & Agonists

Fluorescent Dye

Biochemical Assay Reagents

Peptides

Inhibitory Antibodies

Natural
Products

Recombinant Proteins

Isotope-Labeled Compounds

Antibodies

Click Chemistry

peptide-1

Inhibitors & Agonists

Fluorescent Dye

Biochemical Assay Reagents

Peptides

Inhibitory Antibodies

NaturalProducts

Recombinant Proteins

Isotope-Labeled Compounds

Antibodies

Click Chemistry

Natural
Products